Reuters: Cisplatin not effective in anal cancer trial: study

[NaDiNe]

Cisplatin not effective in anal cancer trial: study
      

CHICAGO (Reuters) - Treating anal cancer patients with the cancer-fighting drug cisplatin to try to shrink tumors before beginning standard therapy did not boost survival rates, and is not recommended, U.S. researchers said on Tuesday.
<p>You are not allowed to view links. Register or Login</p><div class="feedflare">
You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login
</div><img src="You are not allowed to view links. Register or Login" height="1" width="1"/>
      

You are not allowed to view links. Register or Login